Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer

Lung Cancer

Volumn 42, Issue 2, 2003, Pages 163-170

  Kim, Hyung Seok ^a   Youm, Hyung Roul ^b   Lee, Ji Shin ^a   Min, Kyung Whan ^c   Chung, Jae Hun ^d   Park, Chang Soo ^d  

^a Seonam University   (South Korea)

^b Hankook Hospital   (South Korea)

^c Deaconess Hospital Oklahoma City   (United States)

^d Chonnam National University Medical School   (South Korea)

Author keywords

COX 2; Microvessel density; Non small cell lung cancer; VEGF

Indexed keywords

CYCLOOXYGENASE 2; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL TIME; TUMOR CLASSIFICATION; TUMOR VOLUME;

EID: 0142011063     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(03)00290-3     Document Type: Article

References (29)

1. Dubois R.N., Abramson S.B., Crofford L., et al. Cyclooxygenase in biology and disease. FASEB J. 12:1998;1063-1073.
2. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271:1996;33157-33160.
3. Jones D.A., Carlton D.P., McIntyre T.M., Zimmerman G.A., Prescott S.M. Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. Biol. Chem. 268:1993;9049-9054.
4. Ristimaki A., Honkanen N., Jankala H., Sipponen P., Harkonen M. Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res. 57:1997;1276-1280.
5. Zimmermann K.C., Sarbia M., Weber A.A., Borchard F., Gabbert H.E., Schror K. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res. 59:1999;198-204.
6. Masunaga R., Kohno H., Dhar D.K., et al. Cyclooxygenase-2 expression correlates with tumor neovascularization and prognosis in human colorectal carcinoma patients. Clin. Cancer Res. 6:2000;4064-4068.
7. Wolff H., Saukkonen K., Anttila S., Karjalainen A., Vainio H., Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 58:1998;4997-5001.
8. Hasturk S., Kemp B., Kalapurakal S.K., Kurie J.M., Hong W.K., Lee J.S. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma. Cancer. 94:2002;1023-1031.
9. Hosomi Y., Yokose T., Hirose Y., et al. Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung. Lung Cancer. 30:2000;73-81.
10. Rioux N., Castonguay A. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicylic acid and NS-398. Cancer Res. 58:1998;5354-5360.
11. Marrogi A.J., Travis W.D., Welsh J.A., et al. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma. Clin. Cancer Res. 6:2000;4739-4744.
12. Folkman J. Tumor angiogenesis: therapeutic implication. New Engl. J. Med. 285:1971;1182-1186.
13. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447.
14. Cheng T., Cao W., Wen R., Steinberg R.H., LaVail M.M. Prostaglandin E2 induces vascular endothelial growth factor and basic fibroblast growth factor mRNA expression in cultured rat Muller cells. Invest. Ophthalmol. Vis. Sci. 39:1998;581-591.
15. Ben-Av P., Crofford L.J., Wilder R.L., Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 372:1995;83-87.
16. Mountain C.F. The international system for staging lung cancer. Semin. Surg. Oncol. 18:2000;106-115.
17. Offersen B.V., Pfeiffer P., Hamilton-Dutoit S., Overgaard J. Patterns of angiogenesis in nonsmall-cell lung carcinoma. Cancer. 91:2001;1500-1509.
18. Vermeulen P.B., Gasparini G., Fox S.B., et al. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur. J. Cancer. 32A:1996;2474-2484.
19. Kim H.S., Kang H.S., Messam C.A., Min K.W., Park C.S. Comparative evaluation of angiogenesis in gastric adenocarcinoma by nestin and CD34. Appl. Immunohistochem. Mol. Morphol. 10:2002;121-127.
20. Pezzella F., Di Bacco A., Andreola S., Nicholson A.G., Pastorino U., Harris A.L. Angiogenesis in primary lung cancer and lung secondaries. Eur. J. Cancer. 32A:1996;2494-2500.
21. Mountain C.F. Lung cancer staging classification. Clin. Chest Med. 14:1993;43-53.
22. Hida T., Leyton J., Makheja A.N., et al. Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal antiinflammatory drugs. Anticancer Res. 18:1998;775-782.
23. Soslow R.A., Dannenberg A.J., Rush D., et al. COX-2 is expressed in human pulmonary, colonic, and mammary tumors. Cancer. 89:2000;2637-2645.
24. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J. Mol. Med. 77:1999;527-543.
25. Schmedtje J.F. Jr, Ji Y.S., Liu W.L., DuBois R.N., Runge M.S. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J. Biol. Chem. 272:1997;601-608.
26. Sabo E., Boltenko A., Sova Y., Stein A., Kleinhaus S., Resnick M.B. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin. Cancer Res. 7:2001;533-537.
27. Kakolyris S.A., Kaklamanis L.G., Koukourakis M.J., et al. Angiogenesis and p53 expression in the colorectal adenoma-carcinoma sequence. Oncol. Res. 12:2000;203-208.
28. Jones M.K., Wang H., Peskar B.M., et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing. Nat. Med. 5:1999;1418-1423.
29. Majima M., Hayashi I., Muramatsu M., Katada J., Yamashina S., Katori M. Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants. Br. J. Pharmacol. 130:2000;641-649.